Shares of Cardiovascular Systems Inc. (NASDAQ:CSII) dropped 2% during mid-day trading on Monday . The company traded as low as $20.88 and last traded at $20.91, with a volume of 140,869 shares changing hands. The stock had previously closed at $21.33.

CSII has been the topic of a number of recent research reports. Leerink Swann reiterated a “market perform” rating and issued a $15.00 price objective (up from $13.00) on shares of Cardiovascular Systems in a report on Saturday, May 7th. Zacks Investment Research raised shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $21.00 target price for the company in a research note on Monday, July 4th. Needham & Company LLC raised their target price on shares of Cardiovascular Systems from $16.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, May 5th. Finally, Bank of America Corp. raised shares of Cardiovascular Systems from an “underperform” rating to a “neutral” rating in a research note on Thursday. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $21.57.

The company has a 50-day moving average price of $18.97 and a 200-day moving average price of $14.10. The company’s market capitalization is $686.54 million.

Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, August 3rd. The medical device company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.05. The business had revenue of $48.50 million for the quarter, compared to the consensus estimate of $46.01 million. Cardiovascular Systems’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.27) earnings per share. Equities analysts predict that Cardiovascular Systems Inc. will post ($0.64) EPS for the current year.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.